Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
The current price of OC50.F is €52 EUR — it has increased by +2.97% in the past 24 hours. Watch Cochlear stock price performance more closely on the chart.
What is Cochlear stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cochlear stocks are traded under the ticker OC50.F.
Is Cochlear stock price growing?▼
OC50.F stock has risen by +5.26% compared to the previous week, the month change is a -12.61% fall, over the last year Cochlear has showed a -32.47% decrease.
When is the next Cochlear earnings date?▼
Cochlear is going to release the next earnings report on August 13, 2026.
What were Cochlear earnings last quarter?▼
OC50.F earnings for the last quarter are 1.68 EUR per share, whereas the estimation was 1.77 EUR resulting in a -5.41% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cochlear revenue for the last year?▼
Cochlear revenue for the last year amounts to 2.68B EUR.
What is Cochlear net income for the last year?▼
OC50.F net income for the last year is 442.11M EUR.
Does Cochlear pay dividends?▼
Yes, OC50.F dividends are paid semi-annual. The last dividend per share was 0.59 EUR. As of today, Dividend Yield (FWD)% is 2.47%.
How many employees does Cochlear have?▼
As of April 02, 2026, the company has 5,500 employees.